Product logins

Find logins to all Clarivate products below.


Dental Implants | Market Insights | Asia Pacific | 2023

The Asia Pacific dental implant market saw significant negative impact from the COVID-19 pandemic in 2020. However, the market experienced recovery beginning in late 2020 and through 2021 as pandemic-related restrictions eased and vaccination rates improved in the Asia Pacific region, resulting in procedure volume growth. Beyond the impact of the pandemic, the Asia Pacific dental implant market will exhibit rapid growth through 2031, driven by the expanding aging population and rising awareness of dental implant procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for dental implants in Asia Pacific from 2019 through 2031.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Dental Implants – Market Insights – Europe
The European dental implant market is projected to experience modest expansion through 2035. Growth is driven by an aging population with ongoing long-term restorative needs, a persistent burden of…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…